Management & Board

Mr Kroell has been a Venture Capital professional over many years prior to joining De.mem. In his last role, he was Director and Partner of New Asia Investments Pte Ltd, a Singapore-based technology investment firm. He had been responsible for numerous investments in companies from the water, industrial and med tech sectors. Before that, he was with Nanostart AG, a German publicly listed nanotechnology-focused Venture Capital fund. Besides, he held roles in corporate finance and audit with Deutsche Bank and Deloitte & Touche in Germany.

David brings in more than 15 years of experience in the membrane industry. He has worked for companies from the water industries such as Mann & Hummel and Hyflux, Singapore, in different departments, with a focus on the membrane and related technologies.

Bernd Dautel is a Director and Partner with New Asia Investments since 2012. Prior to this, he was the Managing Director of Wieland Asia/Pacific in Singapore. The Wieland group with headquarters in Germany is one of the world’s leading independent producers of semi-finished copper and copper alloy products. Under Bernd’s lead, over a period of 18 years, Wieland‘s business in the Asia / Pacific region grew from a small enterprise to an organization generating more than 400 million SGD in revenues per year.

Mr Edwards is a Geologist and Economist with over 20 years of experience in Senior Management in both the private and public sector. He holds a Bachelor of Business (Economics and Finance) from Curtin University of Technology and a Bachelor of Science (Geology) from the University of Western Australia. Mr Edwards spent three years with Barclays Australia in their corporate finance department and then eight years as an exploration and mine geologist with companies such as Gold Mines of Australia, Eagle Mining and International Mineral Resources. Mr Edwards also acts as the Executive Chairman of ASX listed Auroch Minerals Ltd (ASX: AOU) and as Non-Executive Chairman of Greenstone Resources (ASX: GSR).

Mr Trimigliozzi looks back at a successful, almost 30-year long career in the feed and food ingredients / flavors & fragrances industry, an important target market for De.mem Pte Ltd. In his last assignment, he was the COO of Wild Flavors International, Germany, responsible in particular for the Asian and South American business expansion. Mr Trimigliozzi was a member of the key management team involved in the sale of Wild Flavors on behalf of owner Mr. Wild and private equity investor KKR to ADM Group for approx. 2.5 billion USD. Prior to that, Mr. Trimigliozzi had been in other senior management roles, amongst other as Managing Director – Asia for Givaudan, a multinational corporation from Switzerland.

Mr Carmichael is a Chartered Accountant with over 20 years’ experience in the provision of corporate advisory services both within Australia and internationally. Mr Carmichael is a principal and director of Ventnor which specialises in the provision of corporate and financial advice to small cap ASX listed companies including capital raisings, IPO’s, corporate restructures and mergers and acquisitions. Mr Carmichael graduated from the University of Western Australia with a Bachelor of Commerce degree in 1995, gaining experience with KPMG Corporate Finance in Perth and London before joining ASX listed property services and engineering company UGL Limited (ASX:UGL).

Danny was Veolia’s CEO and Managing Director for the Australia & New Zealand region from 2018 to 2020, responsible for Veolia’s broad portfolio of water, waste and energy operations with more than 4,000 employees and 240 locations. Veolia’s Australian & New Zealand water and waste water business serves many clients from local and state government authorities to the oil & gas, mining, health care, food & beverage industries.

Danny’s long-term career at Veolia started originally with an appointment at Collex Waste Management in 1998. He advanced within Veolia group over more than two decades and held several leadership positions during these years.

Harry De Wit is a senior corporate executive who has worked in several locations across the globe. He has been the CEO of Asia Pacific for Fresenius Medical Care since 2016. In this role, he has also been responsible for the company’s operations in Australia & New Zealand. In addition, he served as a member of Fresenius Medical Care’s management board from 2016 to 2021. Prior to this, Mr. De Wit held further senior corporate roles within the healthcare industry, amongst others with Covidien (previously named Tyco Healthcare).

Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases. The company operates more than 4,100 dialysis clinics and 42 production sites for dialysis products globally. In Australia alone, the group has 23 dialysis clinics and more than 350 staff. Fresenius Medical Care is listed on the Frankfurt Stock Exchange and the New York Stock Exchange, being a member of the German DAX index, which represents 40 of the largest and most liquid companies that trade on German stock markets.